Effect of lifestyle interventions on carotid arterial structure - The DR's EXTRA study.


Journal

Preventive medicine
ISSN: 1096-0260
Titre abrégé: Prev Med
Pays: United States
ID NLM: 0322116

Informations de publication

Date de publication:
03 2023
Historique:
received: 14 09 2022
revised: 25 01 2023
accepted: 27 01 2023
pubmed: 2 2 2023
medline: 3 3 2023
entrez: 1 2 2023
Statut: ppublish

Résumé

No lifestyle-based interventions with medium-term duration on carotid atherosclerotic have been performed so far. We aimed to investigate whether guideline-based dietary and physical activity interventions slow the progression of atherosclerotic changes in the general elderly population. 1410 Finnish men and women from a representative population sample were randomly assigned to one of six groups in the four-year intervention study: 1) reference, 2) aerobic training, 3) resistance training, 4) Nordic Diet, 5) aerobic training + Nordic Diet, 6) resistance training + Nordic Diet. The primary outcome was mean common carotid artery intima-media thickness (cIMT). The lumen diameter of the common carotid artery (cLD) was also analyzed. 567 men and 565 women aged 57 to 78 years were included. None of the intervention groups significantly slowed cIMT progression compared to the reference group. A subgroup analysis showed that men in the diet group had significantly smaller cIMT progression than in the reference group (-0.078 mm, 95% CI: -0.146 to -0.009, p = 0.02) and no significant increase in cIMT (p = 0.23). No other group showed a slowed cIMT progression. Among guideline-based lifestyle interventions, only diet leads to a significantly smaller progression of cIMT in older men of a representative population sample. No other lifestyle intervention contributed to a slowing of the progression of structural carotid markers. It must be questioned whether the guideline-based recommendations for a lifestyle change that were in place until recently are adequate to decelerate the atherosclerotic process.

Identifiants

pubmed: 36724843
pii: S0091-7435(23)00016-6
doi: 10.1016/j.ypmed.2023.107436
pii:
doi:

Banques de données

ISRCTN
['ISRCTN45977199']

Types de publication

Randomized Controlled Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

107436

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare no conflict of interest.

Auteurs

Gilles Nève (G)

Division of Sports and Exercise Medicine, Department of Sport, Exercise and Health, University of Basel, Grosse Allee 6, CH-4052 Basel, Switzerland. Electronic address: gilles.neve@unibas.ch.

Pirjo Komulainen (P)

Kuopio Research Institute of Exercise Medicine, Haapaniementie 16, 70820 Kuopio, Finland. Electronic address: pirjo.komulainen@uef.fi.

Kai Savonen (K)

Kuopio Research Institute of Exercise Medicine, Haapaniementie 16, 70820 Kuopio, Finland; Department of Clinical Physiology and Nuclear Medicine, Science Service Center, Kuopio University Hospital, 70210 Kuopio, Finland. Electronic address: kai.savonen@uef.fi.

Maija Hassinen (M)

Kuopio Research Institute of Exercise Medicine, Haapaniementie 16, 70820 Kuopio, Finland.

Reija Männikkö (R)

Kuopio Research Institute of Exercise Medicine, Haapaniementie 16, 70820 Kuopio, Finland.

Denis Infanger (D)

Division of Sports and Exercise Medicine, Department of Sport, Exercise and Health, University of Basel, Grosse Allee 6, CH-4052 Basel, Switzerland. Electronic address: denis.infanger@unibas.ch.

Arno Schmidt-Trucksäss (A)

Division of Sports and Exercise Medicine, Department of Sport, Exercise and Health, University of Basel, Grosse Allee 6, CH-4052 Basel, Switzerland. Electronic address: arno.schmidt-trucksaess@unibas.ch.

Rainer Rauramaa (R)

Kuopio Research Institute of Exercise Medicine, Haapaniementie 16, 70820 Kuopio, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH